Recalled Device Costs, Test Payments Focus In OIG Work Plan
Executive Summary
The Health & Human Services’ watchdog branch plans to look at a spike in recall costs; Medicare’s progress in implementing lab-test payment reforms; and an ongoing review of FDA’s work on device cybersecurity issues.